BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21623661)

  • 1. Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection.
    Abou-Zeid AA; El-Sayegh HK
    Scand J Clin Lab Invest; 2011 Oct; 71(6):456-61. PubMed ID: 21623661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.
    Wörnle M; Schmid H; Banas B; Merkle M; Henger A; Roeder M; Blattner S; Bock E; Kretzler M; Gröne HJ; Schlöndorff D
    Am J Pathol; 2006 Feb; 168(2):370-85. PubMed ID: 16436653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Toll-like receptors in chronic hepatitis C virus infection.
    Sato K; Ishikawa T; Okumura A; Yamauchi T; Sato S; Ayada M; Matsumoto E; Hotta N; Oohashi T; Fukuzawa Y; Kakumu S
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1627-32. PubMed ID: 17845690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
    J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
    Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C markers in glomerular diseases.
    Enríquez R; Rodríguez JC; Sirvent AE; Amorós F; Ardoy F; Alvarez M; Royo G
    Scand J Urol Nephrol; 2007; 41(6):535-8. PubMed ID: 17853005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
    Lee SO; Brown RA; Razonable RR
    Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.
    Yang Q; Fu S; Wang J
    Arch Virol; 2014 Nov; 159(11):2997-3003. PubMed ID: 25008898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
    Shehata MA; Abou El-Enein A; El-Sharnouby GA
    Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption.
    Carrière M; Rosenberg AR; Conti F; Chouzenoux S; Terris B; Sogni P; Soubrane O; Calmus Y; Podevin P
    J Viral Hepat; 2006 Sep; 13(9):633-42. PubMed ID: 16907851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver.
    Jiang M; Broering R; Trippler M; Wu J; Zhang E; Zhang X; Gerken G; Lu M; Schlaak JF
    J Viral Hepat; 2014 Feb; 21(2):99-110. PubMed ID: 24383923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.
    Tarantino G; Di Cristina A; Pipitone R; Almasio PL; Di Vita G; Craxi A; Grimaudo S
    J Biol Regul Homeost Agents; 2013; 27(1):233-9. PubMed ID: 23489702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Viral Hepat; 2011 Oct; 18(10):e561-7. PubMed ID: 21914077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effect of hepatitis C virus on mitogen-stimulated peripheral blood mononuclear cells: potential role in viral persistence in Egyptian patients.
    Hassan MI; Kassim SK; Ahmad MI; Fawzy S
    Clin Biochem; 2007 Nov; 40(16-17):1173-9. PubMed ID: 17888896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.
    Cao Y; Zhang Y; Wang S; Zou W
    Nephrol Dial Transplant; 2009 Sep; 24(9):2745-51. PubMed ID: 19377056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha.
    Mohammed KI; Adel LA; Ali-Eldin FA; Eladawy S
    Egypt J Immunol; 2013; 20(1):13-22. PubMed ID: 23888553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy.
    Huang YW; Lin SC; Wei SC; Hu JT; Chang HY; Huang SH; Chen DS; Chen PJ; Hsu PN; Yang SS; Kao JH
    Antivir Ther; 2013; 18(7):877-84. PubMed ID: 23744559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.